HEALTH.2013.4.2-1
HEALTH.2013.4.2-1
5 projects · €29,467,233 total EU contribution (project-level) · 52 participating organizations · 17 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€29,467,233
Countries active
Participant organizations by country (headquarters in CORDIS).
- Italy (11)
- UK (9)
- Germany (4)
- Spain (4)
- France (4)
- Netherlands (4)
- AT (2)
- BE (2)
- CH (2)
- EE (2)
- EL (2)
- AL (1)
- CZ (1)
- DK (1)
- HU (1)
- RS (1)
- SE (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ERASMUS MC3 projects · NL
- CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE2 projects · IT
- FONDAZIONE PENTA ETS2 projects · IT
- OSPEDALE PEDIATRICO BAMBINO GESU2 projects · IT
- SERMAS2 projects · ES
- UNIVERSITY OF TARTU2 projects · EE
- THE UNIVERSITY OF LIVERPOOL2 projects · UK
- THERAKIND2 projects · UK
- Universitätsklinikum Erlangen2 projects · DE
- UNIVERSITY COLLEGE LONDON2 projects · UK
- ARISTOTLE UNIVERSITY OF THESSALONIKI1 projects · EL
- ARTTIC1 projects · FR
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Metformin for treatment of polycystic ovary syndrome in children METFIZZ · 602243 | FP7 | €5,999,962 | €8,624,558 | Details |
GAbapentin in Paediatric Pain GAPP · 602962 | FP7 | €5,476,875 | €7,191,563 | Details |
Clonidine for Sedation of Paediatric Patients in the Intensive Care Unit CLOSED · 602453 | FP7 | €5,997,405 | €7,498,976 | Details |
Labeling of Enalapril from Neonates up to Adolescents LENA · 602295 | FP7 | €5,999,991 | €7,478,652 | Details |
Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months NEOVANC · 602041 | FP7 | €5,993,000 | €7,721,444 | Details |